MIF-CD74 signaling drives immune modulation in medulloblastoma

Our multifaceted approach identified key tumor-immune interactions in medulloblastoma. Among these, MIF-CD74 was validated as a targetable interaction, demonstrating the utility of our integrative approach for identifying novel therapeutic targets across multiple tumor types.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2026-02-03
DOI
https://doi.org/10.1093/neuonc/noag020
Primary Topic
Macrophage Migration Inhibitory Factor
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MIF-CD74 signaling drives immune modulation in medulloblastoma

Bethany Remeniuk, Colin Kwok, Carlos Custódia, Olivier Ayrault et al.
Neuro-Oncology
Macrophage Migration Inhibitory Factor
article

MIF-CD74 signaling drives immune modulation in medulloblastoma

Bethany Remeniuk, Colin Kwok, Carlos Custódia, Olivier Ayrault, Chantelle Bowers, Anya Fletcher, Sonia Morlando, Olivier Saulnier, Natalie Monteiro, Barbara Martins Da Costa, Alaide Morcavallo, A. Delaidelli, Laura Donovan, Olumide Ogunbiyi, Rebecca M. Hill, Sumana Shrestha, Stacey Richardson, Zhen You, Miao Liu, Regan Barfoot, Tony Jackson, Darren Locke, Courtney Himsworth, Diego Chillón Pino, Louis Chesler, Poul H. Sorensen, Sergi Castellano, Yara Sanchez-Corrales, Claudia C Faria, Brandon Wade, Freya Gordon, L Frank Huang, Thomas S Jacques, Dean Thompson, Rafael Roque, Benjamin Draper, Karen Barker, Xu Guo, Kevin Greenslade, Jacob Torrejon Diaz, Bei Hopkins, Carlos Lorenzo Gido Nery, John Anderson
article en

Abstract

Our multifaceted approach identified key tumor-immune interactions in medulloblastoma. Among these, MIF-CD74 was validated as a targetable interaction, demonstrating the utility of our integrative approach for identifying novel therapeutic targets across multiple tumor types.

Neuro-Oncology
Université Paris-Sud (FR), BC Cancer Agency (CA), Centre National de la Recherche Scientifique (FR), Mayo Clinic (US), University of Lisbon (PT), Institute of Cancer Research (GB), Inserm (FR), Baylor College of Medicine (US), Université Paris Sciences et Lettres (FR), Université Paris-Saclay (FR), Great Ormond Street Hospital (GB), Massachusetts General Hospital (US), Hospital Universitário de Santa Maria (BR), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), Texas Children's Hospital (US), Hospital de Santa Maria (PT), Children's Cancer Center (US), Canadian Centre for Applied Research in Cancer Control (CA), Akoya Biosciences (United States) (US), University College London (GB), Instituto Gulbenkian de Ciência (PT), Newcastle University (GB)
Openalex Percentile: Top 63%
Macrophage Migration Inhibitory Factor
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.